RRR · NASDAQ · STOCK
Red Rock Resorts (RRR) Stock Analysis
$53.29
52W $50.52 – $68.99
51/100
$3.15B
13.8
1.31
Is RRR Bullish or Bearish?
Mixed.
Innellis AI committee rates Red Rock Resorts, Inc. (RRR) Watch with a composite score of 51/100
, based on 6 analysts with 50% agreement.
Last updated September 17, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.16 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.84 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 16.50) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 91.1% shows genuine earnings power backing the valuation — Value
- EPS growing 30.8% YoY — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
- News sentiment is positive (+0.18 across 11 articles, 14d) — News
Bear Case
- P/E of 33.5 is moderate-to-rich — Value
- Price-to-book of 31.5x prices in significant intangible value — Value
- Debt-to-equity of 16.50 adds balance-sheet risk to the value case — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- RSI at 25 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 17, 2026
Overall Committee Score
51/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 82%
of 178 Consumer Cyclical peers
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 91.1% shows genuine earnings power backing the valuation
− P/E of 33.5 is moderate-to-rich
Growth Analyst
bullish
60
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 30.8% YoY
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
bearish
38
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 25 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst
bearish
33
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 16.50) amplifies downside in a stress scenario
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.18 across 11 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2514.55)
Investment Thesis Evolution
Committee score moved marginally from 50.8 to 50.8.
Comparing 2026-09-16 to 2026-09-17 (1 day apart).
Technical Analysis
RSI (14)
25.2
Oversold
MACD Histogram
-0.220
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$52.14
Resistance
$63.28
Bollinger %B
0.12
Inside Bands
Price vs Moving Averages
EMA 9
$55.62
Below
EMA 21
$57.56
Below
EMA 50
$59.59
Below
EMA 200
$59.13
Below
Fundamental Analysis
Valuation
33
Growth
65
Profitability
70
Financial Health
0
Cash Flow
70
Valuation
P/E Ratio
13.8×
P/B Ratio
18.21×
PEG Ratio
17.80
Dividend Yield
3.79%
52W High
$68.99
52W Low
$50.52
Quality & Growth
ROE
9027.3%
ROA
451.3%
Gross Margin
5675.0%
Operating Margin
2766.8%
Revenue Growth YoY
—
Debt / Equity
21.21
AI Fundamental Assessment
P/E ratio of 13.8 (inexpensive relative to a 15-40x range); Price-to-book of 18.2x; PEG ratio of 17.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 90.3%; Return on assets of 4.5%; Net margin of 8.4%; Gross margin of 56.7%; Current ratio of 0.68 (tight short-term liquidity); Debt-to-equity of 21.21; Free cash flow per share is positive (9.29); Most recent quarter beat estimates by 15.5%; 4 consecutive earnings beats; EPS growth decelerating (-2.7% -> -8.2% QoQ); Analyst estimates falling over recent quarters
Get the Full RRR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →